Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
12.76
1.11 (9.53%)
At close: Aug 18, 2025, 2:45 PM

Pharming Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Aug 5, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
4.66M -11.79M 6.68M 1.51M -1.2M -12.42M -2.72M 3.31M 3.39M -16.67M -18.08M 9.28M 19.56M 4.23M 1.64M 908.1K 7.35M 12.41M
Depreciation & Amortization
n/a 2.58M 7.7M 2.75M -293K 5.91M 7.62M 2.9M 3.16M 2.31M 6.97M 1.95M 2.07M 2.19M 10.8M 2.19M 2.46M 2M
Stock-Based Compensation
n/a 2.58M 2.64M 2.92M 3.26M 2.43M 3.32M 1.97M 2.41M 1.56M 1.87M 1.64M 1.81M 1.07M 2.87M 1.78M 1.89M 1.85M
Other Working Capital
n/a -2.88M -7.09M 5.56K 7.13M 28K -579K -40.37K 265.41K 145.74K 83.85K 266.42K -57.15K -3.13M 2.99M 3.78M -4.76M -1.32M
Other Non-Cash Items
6.1M 5.44M -604K -4.79M 6.51M 10.79M 24.13M -1.27M 494K 2.23M 10.7M -2.66M -17.87M -1.46M -2.59M -2.82M 5.24M -7.42M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -19.35M 1.19M -20.27M n/a n/a n/a n/a n/a -204K -119.05K -311.68K -71.51K
Change in Working Capital
1.66M 1.42M -7.08M 7.35M -9.24M -1.07M -804.25K -4.56M 1.2M -12.21M 4.21M 2.4M -1.57M -5.42M 1.09M 3.07M -7.28M -1.91M
Operating Cash Flow
12.42M 232K 9.33M 9.74M -13.17M -9.68M 12.18M 3.53M -9.62M -22.79M 5.67M 12.62M 4M 609K 13.62M 5.01M 9.35M 6.85M
Capital Expenditures
-131.07K -288K -128.92K -366K -213.73K -79.81K -331.44K -147K -771K -215K -315K -104K -1.18M -375K -5.26M -2.63M -4.75M -2.87M
Cash Acquisitions
-460.61K -57.89M n/a n/a n/a n/a n/a 145.68M n/a n/a -84K -194K 7.58M n/a n/a n/a -385.68K 385.68K
Purchase of Investments
-21.13K n/a -62.06M -109.8M -17.72M -94.56M -150.33M -232.27M n/a n/a 104.21K 183.5K -7.55M n/a -39K n/a n/a n/a
Sales Maturities Of Investments
17.73M 67.87M 52.41M 114.62M 54.27M 95.3M 146.58M 86.59M n/a n/a -16.42K -228.4K 7.55M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -1.09K -108.58K -2.19M 689.46K 174.95K -145.43M 21.08M n/a -87.79K 44.9K -1K 1K n/a -4.44M n/a -0.00
Investing Cash Flow
17.12M 9.69M -9.79M 4.35M 36.34M 662.44K -3.91M -145.57M 20.31M -215K -399K -298K 6.39M -374K -5.29M -7.07M -5.13M -2.49M
Debt Repayment
n/a -715K -1.52M -1.19M -30.89M -1.23M -1.16M -1.01M -1.26M -1.21M -926K -791K -787K -807K -819.48K -800.51K -1.06M -458K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -636.9K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.37M -6M -1.87M -243K 2.58M -1.24M 138.52K 6.25M -514.32K -2.12M 47K -1.95M 48K -2.1M -1.22M -1.37M -21.22M -2.6M
Financial Cash Flow
-314.89K -6.72M -2.2M -1.43M -28.27M -438.96K -1.03M 5.24M -2.63M -2.63M 278K -1.92M -451K -2.89M -417K -2.17M -22.37M -2.31M
Net Cash Flow
34.72M 5.15M -5.72M 13.52M -4.75M -9.85M 6.88M -137.72M 7.59M -22.56M 18.64M -1.26M 290K -2.25M 11.3M -5.08M -17.87M 10.4M
Free Cash Flow
12.29M -56K 9.2M 9.38M -13.39M -9.76M 11.85M 3.38M -10.39M -23M 5.36M 12.51M 2.81M 234K 8.37M 2.38M 4.6M 3.98M